Finance

Lists
LALPATHLAB:NSE
Dr. Lal PathLabs Ltd
1 932,00 INR
+1,12%
(+21,40) 1D
14-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LALPATHLAB...
Open
1 910,60 INR
High
1 942,00 INR
Low
1 887,10 INR
Mkt. cap
160,20 млд
Avg. vol.
315,53 миң
Volume
223,89 миң
Dividend
0,83%
Quarterly dividend
4,00 INR
Ex-dividend date
2026-ж., 25-июн.
P/E ratio
59,63
52-wk high
2 038,60 INR
52-wk low
1 272,60 INR
EPS
32,40 INR
Shares outstanding
83,34 млн
No. of employees
5 миң
Open
1 910,60 INR
High
1 942,00 INR
Low
1 887,10 INR
Mkt. cap
160,20 млд
Avg. vol.
315,53 миң
Volume
223,89 миң
Dividend
0,83%
Quarterly dividend
4,00 INR
Ex-dividend date
2026-ж., 25-июн.
P/E ratio
59,63
52-wk high
2 038,60 INR
52-wk low
1 272,60 INR
EPS
32,40 INR
Shares outstanding
83,34 млн
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia
About Dr. Lal PathLabs Ltd
CEO-
Employees5,21 миң
Founded1949
Headquarters-
SectorHealth care provider
Last report
2026-ж., 24-июл.
Fiscal period
Q1 2027
10,13 INR / 10,31 INR
-1,78%miss
Revenue / Est. (INR)
7,98 млд / 7,58 млд
+5,22%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
7,31 млд
6,60 млд
7,03 млд
7,98 млд
Cost of goods sold
2,74 млд
2,63 млд
3,21 млд
2,84 млд
Cost of revenue
2,74 млд
2,63 млд
3,21 млд
2,84 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,06 млд
958,00 млн
2,32 млд
1,16 млд
Operating expense
2,73 млд
2,59 млд
2,35 млд
3,10 млд
Total operating expenses
5,47 млд
5,23 млд
5,55 млд
5,95 млд
Operating income
1,84 млд
1,37 млд
1,47 млд
2,03 млд
Other non operating income
248,00 млн
244,00 млн
-752,10 млн
319,00 млн
EBT including unusual items
2,04 млд
1,24 млд
1,60 млд
2,29 млд
EBT excluding unusual items
2,04 млд
1,54 млд
1,33 млд
2,29 млд
Income tax expense
514,00 млн
329,00 млн
279,31 млн
582,00 млн
Effective tax rate
25,25%
26,47%
17,45%
25,45%
Other operating expenses
1,26 млд
1,22 млд
-425,41 млн
1,50 млд
Net income
1,51 млд
905,00 млн
1,31 млд
1,70 млд
Net profit margin
20,61%
13,72%
18,68%
21,25%
Earnings per share
9,00
6,73
8,44
10,13
Interest and investment income
-
-
670,12 млн
-
Interest expense
-48,00 млн
-72,00 млн
-61,00 млн
-63,00 млн
Net interest expenses
-48,00 млн
-72,00 млн
609,12 млн
-63,00 млн
Depreciation and amortization charges
405,00 млн
421,00 млн
446,03 млн
444,00 млн
EBITDA
2,21 млд
1,62 млд
1,76 млд
2,32 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору